Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
PH12022550379B1Active Publication Date: 2026-07-01AMGEN INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12022550379
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-02-16
- Publication Date
- 2026-07-01
- Estimated Expiration
- 2042-02-16
Abstract
The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
Need to check novelty before this filing date? Find Prior Art